Earnings History Data for Moleculin Biotech, Inc. (MBRX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Moleculin Biotech, Inc.
Moleculin Biotech, Inc. is a preclinical and clinical-stage pharmaceutical company which focused on the development of anti-cancer drug candidates. The company's lead product candidate is Annamycin, a Phase II clinical stage anthracycline for the treatment of relapsed or refractory acute myeloid leukemia. Moleculin Biotech, Inc. is based in Houston, TX.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 11-11-2024 | PM | MBRX | Moleculin Biotech, Inc. | 6.53 | -2.09 | -2.44 | -2.85 | Moleculin Biotech GAAP EPS of -$2.85 [11/11/2024 7:46 AM] |
2.50 | -0.05 (-1.96%) |
2.72 | 0.17 (6.67%) |
2.12 - 15.75 | 30,321 | 20,000 | 1,609 | ||
| 13-08-2024 | AH | MBRX | Moleculin Biotech | 6.00 | -2.23 | -2.10 | 0.00 | 2.50 | 0.15 (6.38%) |
2.55 | 0.20 (8.51%) |
2.12 - 15.75 | 29,164 | 80,000 | 4,277 | |||
|
|
||||||||||||||||||
| 13-05-2024 | PM | MBRX | Moleculin Biotech, Inc. | 10.47 | -2.02 | -3.59 | -4.20 | Moleculin Biotech GAAP EPS of -$2.02 [5/13/2024 7:44 AM] |
4.63 | -0.13 (-2.73%) |
4.63 | -0.13 (-2.73%) |
4.28 - 15.75 | 12,716 | 40,000 | 11,225 | ||
| 22-03-2024 | AH | MBRX | Moleculin Biotech, Inc. | 14.05 | N/A | -0.20 | -0.24 | Moleculin Biotech GAAP EPS of -$15.07 misses by $2.07 [3/22/2024 4:16 PM] |
5.30 | -0.40 (-7.09%) |
5.99 | 0.29 (5.00%) |
4.65 - 24.75 | 228,386 | 30,000 | 677,463 | ||
|
|
||||||||||||||||||
| 13-11-2023 | PM | MBRX | Moleculin Biotech, Inc. | 16.04 | -0.19 | -0.20 | -0.30 | Moleculin Biotech Q3 GAAP EPS of -$0.19 beats by $0.03 [11/13/2023 10:59 AM] |
0.5725 | 0.03 (6.02%) |
0.58 | 0.04 (7.96%) |
0.34 - 1.65 | 533,355 | 80,000 | 966,815 | ||
| 11-08-2023 | PM | MBRX | Moleculin Biotech, Inc. | 17.81 | -0.20 | -0.28 | -0.24 | Moleculin Biotech GAAP EPS of -$0.20 beats by $0.07 [8/11/2023 6:46 AM] |
0.6350 | 0.0 (0.79%) |
0.57 | -0.06 (-9.57%) |
0.52 - 1.85 | 34,164 | 60,000 | 56,227 | ||
| 11-05-2023 | PM | Before the open (May 11) |
MBRX | Moleculin Biotech, Inc. | 23.15 | -0.28 | -0.25 | -0.24 | Moleculin Biotech GAAP EPS of -$0.28 in-line [5/11/2023 7:08 AM] |
0.7520 | -0.03 (-3.59%) |
0.0 | 0.0 (0.00%) |
0.65 - 1.94 | 31,100 | 80,000 | 0 | |
| 22-03-2023 | PM | 4:05 PM ET (Mar 22) |
MBRX | Moleculin Biotech, Inc. | 36.07 | -0.24 | -0.28 | -0.17 | Moleculin Biotech reports FY results [3/23/2023 7:52 AM] |
0.9351 | -0.09 (-9.21%) |
1.09 | 0.06 (5.83%) |
0.82 - 2.05 | 110,726 | 120,000 | 12,491 | |
| 10-11-2022 | AH | After the close (Nov 10) |
MBRX | Moleculin Biotech, Inc. | 24.89 | -0.30 | -0.27 | -0.15 | Moleculin Biotech GAAP EPS of -$0.30 [11/10/2022 4:33 PM] |
0.9470 | 0.05 (5.15%) |
0.92 | 0.02 (2.15%) |
0.82 - 2.58 | 45,608 | 70,000 | 111 | |
| 15-08-2022 | PM | MBRX | Moleculin Biotech | 47.00 | -0.24 | -0.25 | 0.00 | Moleculin Biotech GAAP EPS of -$0.24 [8/15/2022 8:47 AM] |
3.76 | -0.21 (-5.29%) |
1.64 | 0.02 (1.23%) |
3.68 - 12.42 | 14,481 | 20,000 | 2,997 | ||
| 11-05-2022 | PM | MBRX | Moleculin Biotech, Inc. | 37.15 | -0.24 | -0.21 | -0.20 | Moleculin Biotech GAAP EPS of -$0.24 misses by $0.01 [5/12/2022 8:52 AM] |
1.19 | -0.03 (-2.46%) |
1.23 | 0.01 (0.82%) |
1.02 - 3.99 | 119,993 | 80,000 | 736 | ||
|
||||||||||||||||||
| 25-03-2022 | PM | MBRX | Moleculin Biotech | 46.00 | -0.17 | -0.21 | 0.00 | Moleculin Biotech GAAP EPS of -$0.59 beats by $0.12 [3/25/2022 7:21 AM] |
1.77 | -0.03 (-1.67%) |
1.82 | 0.02 (1.11%) |
1.22 - 4.77 | 132,912 | 184,114 | 0 | ||
| 11-11-2021 | PM | MBRX | Moleculin Biotech | 73.00 | -0.15 | -0.20 | 0.00 | Moleculin Biotech EPS beats by $0.05 [11/11/2021 8:22 AM] |
2.54 | 0.07 (2.83%) |
2.50 | 0.03 (1.21%) |
2.44 - 8.78 | 181,618 | 240,000 | 10,551 | ||
| 12-08-2021 | PM | MBRX | Moleculin Biotech, Inc. | 88.80 | -0.19 | -0.20 | -0.48 | Moleculin Biotech EPS beats by $0.05 [8/12/2021 8:44 AM] |
2.93 | -0.14 (-4.56%) |
3.13 | 0.06 (1.95%) |
2.93 - 8.78 | 255,988 | 140,000 | 3,835 | ||
| 12-05-2021 | PM | MBRX | Moleculin Biotech, Inc. | 98.00 | -0.20 | -0.26 | 0.00 | Moleculin Biotech EPS beats by $0.03 [5/12/2021 7:46 AM] |
3.45 | 0.05 (1.47%) |
3.45 | 0.05 (1.47%) |
3.12 - 9.30 | 461,725 | 250,000 | 6,554 | ||
|
||||||||||||||||||
| 24-03-2021 | ?? | 7:30 AM ET (Mar 24) |
MBRX | Moleculin Biotech, Inc. | 112.54 | N/A | -0.61 | -0.48 | Moleculin Biotech EPS beats by $0.37 [3/24/2021 7:39 AM] |
3.93 | 0.12 (3.15%) |
3.74 | -0.07 (-1.84%) |
3.14 - 11.82 | 323,459 | 750,000 | 39,959 | |
| 13-11-2020 | PM | MBRX | Moleculin Biotech, Inc. | 44.00 | -0.36 | -0.10 | 0.00 | Moleculin Biotech EPS beats by $0.04 [11/13/2020 7:36 AM] |
0.77 | 0.06 (8.45%) |
0.7252 | 0.02 (2.14%) |
0.32 - 1.97 | 644,110 | 329,956 | 5,521 | ||
|
|
||||||||||||||||||